Marked shrinkage of amyloid lymphadenopathy after an intensive chemotherapy in a patient with IgM-associated AL amyloidosis

References

• Kyle RA, Gertz MA. Primary systemic amyloidosis. Clinical and laboratory features in 474 cases. Semin Hematol 1995;32:45–59.
   PubMed Web of Science ®Google Scholar
• Skinner M, Sanchorawala V, Seldin DC, Dember LM, Falk RH, Berk JL, Anderson JJ, O'Hara C, Finn KT, Libbey CA, Wiesman J, Quillen K, Swan N, Wright DG. High-dose melphalan and autologous stem-cell transplantation in patients with AL amyloidosis: an 8-year study. Ann Intern Med 2004;140:85–93.
   PubMed Web of Science ®Google Scholar
• Sanchorawala V, Seldin DC. An overview of high-dose melphalan and stem cell transplantation in the treatment of AL amyloidosis. Amyloid: J Protein Fold Disord 2007;14:261–269.
   PubMed Web of Science ®Google Scholar
• Matsuda M, Gono T, Shimojima Y, Yoshida T, Katoh N, Hoshii Y, Yamada T, Ikeda S. AL amyloidosis manifesting as systemic lymphadenopathy. Amyloid: J Protein Fold Disord 2008;15:117–124.
   PubMed Web of Science ®Google Scholar
• Gono T, Matsuda M, Shimojima Y, Ishii W, Koyama J, Sakashita K, Koike K, Hoshii Y, Ikeda S. VAD with or without subsequent high-dose melphalan followed by autologous stem cell support in AL amyloidosis: Japanese experience and criteria for patient selection. Amyloid: J Protein Fold Disord 2004;11:245–256.
   PubMed Web of Science ®Google Scholar
• Gillmore JD, Lovat LB, Persey MR, Pepys MB, Hawkins PN. Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein. Lancet 2001;358:24–29.
   PubMed Web of Science ®Google Scholar
• Verbrugghe W, Maes BD, Knockaert DC. Localized plasma-cell type Castleman's disease and AA-amyloidosis cured by resection. A case report and review of literature. Acta Clin Belg 2005;60:22–27.
   PubMed Web of Science ®Google Scholar
• Shimojima Y, Takei Y, Tazawa K, Gono T, Fushimi T, Matsuda M, Hoshii Y, Ikeda S. Histopathological regression of systemic AA amyloidosis after surgical treatment of a localized Castleman's disease. Amyloid: J Protein Fold Disord 2006;13:184–186.
   PubMed Web of Science ®Google Scholar
• Tsuchiya A, Yazaki M, Kametani F, Takei Y, Ikeda S. Marked regression of abdominal fat amyloid in patients with familial amyloid polyneuropathy during long-term follow-up after liver transplantation. Liver Transpl 2008;14:563–570.
   PubMed Web of Science ®Google Scholar
• van Buren M, Hene RJ, Verdonck LF, Verzijbergen FJ, Lokhorst HM. Clinical remission after syngeneic bone marrow transplantation in a patient with AL amyloidosis. Ann Intern Med 1995;122:508–510.
   PubMed Web of Science ®Google Scholar
• van Gameren II, Hazenberg BPC, Jager PL, Smit JW, Vellenga E. AL amyloidosis treated with induction chemotherapy with VAD followed by high dose melphalan and autologous stem cell transplantation. Amyloid: J Protein Fold Disord 2002;9:165–174.
   PubMed Web of Science ®Google Scholar
• Sezer O, Schmid P, Schweigert M, Heider U, Eucker J, Harder H, Sinha P, Radtke H, Possinger K. Rapid reversal of nephrotic syndrome due to primary systemic AL amyloidosis after VAD and subsequent high-dose chemotherapy with autologous stem cell support. Bone Marrow Transplant 1999;23:967–969.
   PubMed Web of Science ®Google Scholar
• Zeier M, Perz BJ, Linke RP, Donini U, Waldherr R, Andrassy K, Ho AD, Goldschmidt H. No regression of renal AL amyloidosis in monoclonal gammopathy after successful autologous blood cell transplantation and significant clinical improvement. Nephrol Dial Transplant 2003;18:2644–2647.
   PubMed Web of Science ®Google Scholar
• Wechalekar AD, Lachmann HJ, Goodman HJB, Bradwell A, Hawkins PN, Gillmore JD. AL amyloidosis associated with IgM paraproteinemia: clinical profile and treatment outcome. Blood 2008;112:4009–4016.
   PubMed Web of Science ®Google Scholar
• Terrier B, Jaccard A, Harousseau JL, Delarue R, Tournilhac O, Hunault-Berger M, Hamidou M, Dantal J, Bernard M, Grosbois B, Morel P, Coiteux V, Gisserot O, Rodon P, Hot A, Elie C, Leblond V, Fermand JP, Fakhouri F. The clinical spectrum of IgM-related amyloidosis: a French nationwide retrospective study of 72 patients. Medicine (Baltimore) 2008;87:99–109.
   PubMed Web of Science ®Google Scholar